FindTrial
Sign In

A medical records based study for the safety of artificial liver cluster nursing in critically ill patients with novel coronavirus pneumonia (COVID-19)

Retrospective study to assess the safety of in vitro blood purification treatment in critically ill patients with novel coronavirus pneumonia COVID-19

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030559
Enrollment
Unknown
Registered
2020-03-07
Start date
2020-03-07
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:clustering nusing progremm

Sponsors

The First Affiliated Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Critically ill patients with SARS-CoV-2 infection who had perform blood purificationtherapy using artificial liver suppoer system and underwent clustering nusing progremm

Exclusion criteria

Exclusion criteria: 1) Patient or family member does not agree to sign informed consent; 2) Patients with previous or existing history of DVT; 3) The investigator believes that the patient has other conditions that are not suitable for enrollment;

Design outcomes

Primary

MeasureTime frame
Unplanned shutdowns;—

Secondary

MeasureTime frame
Incidence of nursing staff infection;Incidence of DVT in the lower extremities;Platelets;Hemoglobin;INR;D-Dimer;—

Countries

China

Contacts

Public ContactZhang Huafen

The First Affiliated Hospital of Zhejiang University, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Disease

zhanghuafen@zju.edu.cn+86 13757120681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026